The effort to develop a coronavirus vaccine has been impressive. Over 190 coronavirus vaccine candidates are in some stage of testing, according to the World Health Organization. Of those, 42 are being evaluated in clinical studies, and 10 have reached late-stage clinical trials
(RTTNews) - U.K. stocks rose on Wednesday, with sentiment helped by a weaker pound ahead of a U.K.-imposed Oct. 15 deadline for progress in Brexit negotiations. The pound was also weighed down by growing political wrangling over new Covid-19 restrictions.
(RTTNews) - German stocks rose on Wednesday ahead of a speech by European Central Bank President Christine Lagarde, who is expected to reiterate the central bank's dovish stance as Covid-19 concerns continue to linger.
(RTTNews) - Asian stocks fell broadly on Wednesday, with diminishing hopes for the passage of a U.S. coronavirus bill coupled with worries about the development of a Covid-19 vaccine keeping investors cautious.
The European Central Bank will review a key rule forcing it to buy corporate bonds in proportion of their outstanding amounts in light of the market's "failure" to reflect risks related to climate change, ECB President Christine Lagarde said on Wednesday.
(RTTNews) - Security company G4S plc (GFSZY.PK, GFS.L) Wednesday reported that its group revenue for nine months were lower by 2 percent overall, but its underlying earnings remain ahead of the prior year for the same period.
(RTTNews) - BHP Group Plc. (BHP.AX, BLT.L, BBL, BHP) performed solidly in the 2020 financial year, despite the global adversity. Earnings and cash flow were strong. Net debt was at the low end of target range, Ken MacKenzie, Chairman said in the company's annual general meeting.
(RTTNews) - Nestle SA (NSRGY.PK, NSTR.L) announced the completion of its acquisition of Aimmune Therapeutics, Inc. (AIMT). Andrew Oxtoby has been named as Aimmune's President & CEO. He was previously Aimmune's Chief Commercial Officer.
(RTTNews) - Today's Daily Dose brings you news about Lilly temporarily halting phase III trial of COVID-19 antibody, Gossamer Bio's oral GB001 flunking in both asthma and chronic rhinosinusitis trials, encouraging data from Regeneron/Sanofi's Dupixent trial, and Johnson & Jo
(RTTNews) - Pearson Plc (PSO, PSON.L) said, at the nine months, Group sales declined by 14% largely reflecting the continuing impact of COVID-19 and test centre and school closures. Global Online Learning sales grew 14% due to 41% enrolment growth in Virtual Schools for the acad
(RTTNews) - Bunzl plc (BZLFY.PK, BNZL.L) reported that its Group revenue for the third quarter was up 4.0% at actual exchange rates and 8.8% at constant exchange rates. Underlying revenue rose by 8.0% at constant exchange rates. The Group said sales of the top 8 Covid-19 related
(RTTNews) - Dutch semiconductor equipment maker ASML Holding N.V. (ASML) Wednesday reported significantly higher profit for the third quarter, as sales grew year-on-year. The company confirmed its outlook as well as announced an interim dividend for the full year 2020.
(RTTNews) - European stocks are seen opening higher on Wednesday despite concerns surrounding halted Covid-19 vaccine trials and an elusive U.S. stimulus agreement.
U.S. poultry company Pilgrim's Pride Corp said on Wednesday it has agreed to pay a fine of more than $110 million following a Justice Department probe into alleged price-fixing in the sale of broiler chicken products in the United States.
Checked
8 minutes 18 seconds ago
This feed is responsible for generating the rss feed related to the topic Markets